50. Tadakawa, M., et al. (2016, April 26). The prevalence and risk factors of school absenteeism due to premenstrual disorders in Japanese high school students – a school-based cross-sectional study. Biopsychosocial Medicine, 10, 13. https://pmc.ncbi.nlm.nih.gov/articles/PMC4845482/ 51. Vashisht A., et al. (2018 September-December ) School absenteeism during menstruation amongst adolescent girls in Delhi, India. Journal of Family Community Medicine, 25(3), 163–168. https://pubmed.ncbi.nlm.nih.gov/30220845/ 52. Rossi, M. F., et al. (2022, June 8). Sex and gender differences in migraines: A narrative review. Neurological Sciences, 43(9), 5729–5734. https://doi.org/10.1007/s10072-022-06178-6 53. Pakalnis, A. (2016, February). Migraine and hormones. Seminars in Pediatric Neurology, 23(1), 92–94. https://pubmed. ncbi.nlm.nih.gov/27017029/ 54. Rossi, M. F., et al. (2022, June 8). Sex and gender differences in migraines: A narrative review. Neurological Sciences, 43(9), 5729–5734. https://doi.org/10.1007/s10072-022-06178-6 55. Allais, G., et al. (2012, May 30). Premenstrual syndrome and migraine. Neurological Sciences, 33(Suppl 1), 111–115. https://doi.org/10.1007/s10072-012-1054-5 56. Allais, G., et al. (2020, August 26). Gender-related differences in migraine. Neurological Sciences, 41(Suppl 2), 429–436. https://doi.org/10.1007/s10072-020-04643-8 57. World Health Organization. (2023). Endometriosis. https://www.who.int/news-room/fact-sheets/detail/endometriosis 58. DeGroot, L. J. (Ed.). (1989). Endocrinology (vol. 3, 2nd ed.). W. B. Saunders. 59. Horne, A. W., & Missmer, S. A. (2022, November 14). Pathophysiology, diagnosis, and management of endometriosis. BMJ, 379, e070750. https://pubmed.ncbi.nlm.nih.gov/36375827/ 60. Yale Medicine. (2024). Endometriosis. https://www.yalemedicine.org/conditions/endometriosis#:~:text=Endometriosis%20 is%20a%20common%20condition,and%20diagnosis%20(and%20treatment) 61. Macer, M. L., & Taylor, H. (2012, December). Endometriosis and infertility: A review of the pathogenesis and treatment of endometriosis-associated infertility. Fertility and Sterility, 39(4), 535–549. https://pmc.ncbi.nlm.nih.gov/articles/ PMC3538128/#R2 62. Soliman, A. M., et al. (2017, June 26). The effect of endometriosis symptoms on absenteeism and presenteeism in the workplace and at home. Journal of Managed Care & Specialty Pharmacy, 23(7). https://www.jmcp.org/doi/10.18553/ jmcp.2017.23.7.745 63. World Economic Forum & McKinsey Health Institute. (2024). Closing the women’s health gap: A $1 trillion opportunity to improve lives and economies. https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion- dollar-opportunity-to-improve-lives-and-economies 64. Dolgin, E. (2024, February 1). Why autoimmune disease is more common in women: X chromosome holds clues. Nature. https://www.nature.com/articles/d41586-024-00267-6 65. World Health Organization. (2023, March 24). Endometriosis. https://www.who.int/news-room/fact-sheets/detail/ endometriosis 66. Institute for Health Metrics and Evaluation. (n.d.). Endometriosis – level 4 cause. Retrieved November 14, 2024, from https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-endometriosis-level-4-disease 67. World Bank. (2021). Connecting the world. https://wdr2021.worldbank.org/stories/connecting-the-world/ 68. Zhao, L., et al. (2022). Data gaps towards health development goals, 47 low- and middle-income countries. Bulletin of the World Health Organization, 100(1), 40–49. https://doi.org/10.2471/BLT.21.286254 69. World Economic Forum & McKinsey Health Institute analysis (2024). Patient registries are observational studies that collect and store information about patients with conditions over time. For further details on patient registries, and how analyses were carried out, please refer to the technical appendix 70. Agency for Healthcare Research and Quality. (2018). Multinational registries: Challenges and opportunities (3rd ed.). https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/multinational-registries-guide-3rd-ed-addendum_white- paper-2018-1.pdf 71. Soares, L. R., Curado, M. P ., & Freitas-Junior, R. (2021). Breast cancer staging in population-based registries: An alert to the quality of information. Mastology, 31, e20200067. https://www.mastology.org/wp-content/uploads/2021/01/ MAS_2020067_AOP .pdf 72. The WHO’s Mortality Dashboard and Global Cancer Database have different approaches to reporting age-standardized mortality data. The WHO dashboard also relies on data provided by civil registers that are submitted by countries, which can result in missing data. Where data is available, most is not disaggregated by relevant factors such as socioeconomic status, geographic location or age. 73. Minja, N. W., et al. (2022, November 10). Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward. Frontiers in cardiovascular medicine, 9, 1008335. https://doi.org/10.3389/fcvm.2022.1008335 74. For more details on the methodology behind the CPG analysis, please refer to the technical appendix. 75. World Health Organization. (2023). World Health Organization Model List of Essential Medicines. https://iris.who.int/ bitstream/handle/10665/371090/WHO-MHP-HPS-EML-2023.02-eng.pdf?sequence=1 76. World Economic Forum & McKinsey Health Institute analysis. Data retrieved June 2024 Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All 55

Blueprint to Close the Women%E2%80%99s Health Gap 2025